GlassScriptPhysician profile
Edward James Westfall
NPI 1942662986
$2,317.08
in general payments reported to CMS, 2019-2025
17 companies · $455 in 2025
The $455 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $280 · 2020: $20.90 · 2021: $165 · 2022: $271 · 2023: $530 · 2024: $596 · 2025: $455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,580.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $393.96 | 2020-2024 | Xpress Ent Dilation System, Sonopet Iq, Core |
| Genzyme Corporation | $357.84 | 2023-2025 | |
| Acclarent, INC | $281.76 | 2019-2023 | Relieva Spinplus, Acclarent Aera |
| Advanced Bionics, LLC | $237.39 | 2024-2025 | Hires Ultra Ci Hifocus Ms Electrode |
| Integra Lifesciences Corporation | $207.32 | 2019-2025 | Relieva Spinplus Nav, Inspira Air, Acclarent Aera |
| Glaxosmithkline, LLC. | $175.74 | 2021-2024 | Nucala |
| Cochlear Americas | $163.49 | 2021-2025 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Intersect Ent, INC. | $106.63 | 2019 | |
| Optinose US, INC. | $88.01 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $68.80 | 2024-2025 | Dupixent |
| Inspire Medical Systems, INC. | $65.88 | 2023-2024 | Inspire |
| Aerin Medical INC. | $56.23 | 2024 | |
| Baxter Healthcare | $37.68 | 2022 | |
| Kaleo, INC. | $30.92 | 2022-2023 | Auvi-Q |
| Amgen INC. | $16.44 | 2025 | Uplizna |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $14.81 | 2024 | |
| Merck Sharp & Dohme LLC | $14.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Westfall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.